Global /Russian Federation /Healthcare /Medical Care Facilities /GEMA
chevron_leftBack
International Medical Center of Biomaterials Processing and Cryostorage logo

International Medical Center of Biomaterials Processing and Cryostorage

GEMA
MOEX: GEMA Delayed
117.50RUB 1.1%
1.63 USD
As of 11 June 2026, International Medical Center of Biomaterials Processing and Cryostorage has a market cap of $24.73M USD, ranking #35541 globally and #172 in Russian Federation. It ranks #3203 in the Healthcare sector, and #390 in the Medical Care Facilities industry.
Global Rank
35541
Country Rank
172
Sector Rank
3203
Industry Rank
390
Key Stats
Market Cap
$24.73MUSD
1.79B RUB
Enterprise Value
$139.34MUSD
10.03B RUB
Revenue (TTM)
$5.21MUSD
376.74M RUB
EBITDA (TTM)
$2.66MUSD
191.51M RUB
Net Income (TTM)
$2.19MUSD
158.39M RUB
EBITDA Margin
51%
Profit Margin
42%
PE Ratio
63.3
PS Ratio
26.6
PB Ratio
50.6
EV/EBITDA
50.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Prikhodko Viktorovich open_in_new
Employees
15
Founded
2003
Website
gemabank.ru open_in_new
While the market cap, price, and price change data for Russian stocks are up to date, chart data is stale due to data provider issues (and the Ukraine war). For the latest info, visit the TradingView quote.
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.1% -7.2% -6.7% -1.4% 0% -1.5%

News

Loading...

Markets

Exchange Ticker Price
Moscow Exchange
MIC: MISX
PRIMARY
GEMA
Публичное акционерное общество Ordinary Shares
ISIN: RU000A100GC7
Shares Out.:
14.93M1
TV:
SA:
YF:
GF:
BA:
MS:
117.50 RUB
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About International Medical Center of Biomaterials Processing and Cryostorage

International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a personal stem cell storage bank in Russia. The company is also involved in the development of drugs for the treatment of blood and immune system diseases. It stores biomaterial samples, including samples of hematopoietic cord blood stem cells, as well as samples of mesenchymal stem cells and umbilical cord tissue for transplant. The company was founded in 2003 and is based in Moscow, Russia. International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates as a subsidiary of Artgen Biotech PJSC.

Similar Companies

Industry: Medical Care Facilities (Russian Federation)
Name
Market Cap diff.
PE
ABIO
$61.6M
4.45B RUB
149%
-
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.22B
852.82B AED
939K%
44.1
$96.73B
391K%
14.9
$26.53B
22.97B EUR
107K%
15.0
$25.43B
22.02B EUR
103K%
24.9
$22.49B
84.42B SAR
91K%
35.2
$21.13B
85K%
24.6
chevron_leftBack